Dr. Petrylak on a Phase II Trial of PSMA ADC in Taxane-Treated mCRPC Targeted Oncology 1:23 10 years ago 67 Далее Скачать
PSMAfore Results: [177Lu]Lu-PSMA-617 in Taxane-Naive Patients With mCRPC GU Oncology Now 10:20 5 months ago 336 Далее Скачать
Phase I/II dose-escalation study of 225Ac-J591 in progressive mCRPC VJOncology 5:47 3 years ago 216 Далее Скачать
Phase I/II Trial of 177Lu−J591 and 177Lu−PSMA−617 in mCRCP WCMNYP JCTO 2:04 5 years ago 171 Далее Скачать
ASCO 2024 highlights: the PSMAfore trial for patients with mCRPC VJOncology 0:33 5 months ago 122 Далее Скачать
GMF-1A3, a novel ADC targeting cleaved amphiregulin in breast cancer VJOncology 2:03 1 year ago 403 Далее Скачать
ARASENS: the addition of darolutamide to ADT and docetaxel for the treatment of mHSPC VJOncology 1:44 2 years ago 1 073 Далее Скачать
VBIR vaccine shows promise in prostate cancer: Phase I trial results and immunotherapy potential VJOncology 1:30 1 year ago 366 Далее Скачать
Dr. Nicholas Vogelzang Discusses PSMA ADC in Prostate Cancer Targeted Oncology 2:55 11 years ago 704 Далее Скачать
LuPARP: 177Lu-PSMA-617 and PARP inhibitor combination for prostate cancer VJOncology 1:24 1 year ago 192 Далее Скачать
Preliminary findings in mCRPC for fractionated dose 177Lu-PSMA-617 VJOncology 3:01 5 years ago 202 Далее Скачать
